| Patents for A61K 48 - Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy (86,964) |
|---|
| 12/27/2001 | US20010055586 Methods and means for targeted gene delivery |
| 12/27/2001 | US20010055585 Frnk proteins in the treatment of tumor cells |
| 12/27/2001 | US20010055584 Improved nucleic acids encoding a chimeric glycosyltransferase |
| 12/27/2001 | CA2414065A1 Cgi-69 compositions and methods of use |
| 12/27/2001 | CA2414046A1 Conserved diaphanous-related formin autoregulatory domain (dad) |
| 12/27/2001 | CA2414033A1 Control of metabolism with compositions of the human 2-oxoglutarate carrier |
| 12/27/2001 | CA2413986A1 Gp354 nucleic acids and polypeptides |
| 12/27/2001 | CA2413556A1 Positively-charged peptide nucleic acid analogs with improved properties |
| 12/27/2001 | CA2413502A1 Tumour-cell specific gene expression and its use in cancer therapy |
| 12/27/2001 | CA2413468A1 Methods and means for regulation of gene expression |
| 12/27/2001 | CA2413452A1 Clk-2, cex-7 and coq-4 genes, and uses thereof |
| 12/27/2001 | CA2412734A1 Renal regulatory elements and methods of use thereof |
| 12/27/2001 | CA2412215A1 Angiogenesis-modulating compositions and uses |
| 12/27/2001 | CA2412013A1 Polynucleotides encoding human serine proteases |
| 12/27/2001 | CA2411756A1 Mutation associated with epilepsy |
| 12/27/2001 | CA2410864A1 Compositions comprising net-4 modulations and their use for treating neoplastic disease |
| 12/27/2001 | CA2410371A1 Methods for enhancing antibody-induced cell lysis and treating cancer |
| 12/27/2001 | CA2409776A1 G-protein coupled receptors |
| 12/27/2001 | CA2407788A1 Method for activating peroxisome proliferator activated receptor-.gamma. |
| 12/26/2001 | CN1328569A TGF (b) 1 inhibitor peptides |
| 12/26/2001 | CN1328469A Use of parvovirus capsid particles in inhibition of cell proliferation and migration |
| 12/26/2001 | CN1328057A Polypeptide-human FK506 bindin 12.32 and polynucleotide for coding it |
| 12/26/2001 | CN1328017A Polypeptide-human TNFR/NGFR protein 12 containing cytochrome C structure domain and polynucleotide for coding it |
| 12/26/2001 | CN1327855A Gene expressed switchable molecular medicine |
| 12/25/2001 | US6333318 Used in therapy; for delivering recombinant proteins into a variety of cells within a patient |
| 12/25/2001 | US6333182 Human glycosylation enzymes |
| 12/25/2001 | US6333172 An expression system for expressing a nucleic acid encoding polypeptide for 3-hydroxy-3-methylglutaryl coa (hmg coa) reductase degradation (hrd) protein; for assay to screen and regulate cholesterol biosynthesis |
| 12/25/2001 | US6333171 CD4 gene regulatory sequences specifically expressed in mature T cells |
| 12/25/2001 | US6333051 Nanogel networks and biological agent compositions thereof |
| 12/25/2001 | US6333030 Chimeric retrovirus/adenovirus system |
| 12/20/2001 | WO2001096598A2 cDNA FOR HUMAN METHYLENETETRAHYDROFOLATE REDUCTASE AND USES THEREOF |
| 12/20/2001 | WO2001096587A2 Methods for administering recombinant adeno-associated virus virions to humans previously exposed to adeno-associated virus |
| 12/20/2001 | WO2001096586A1 Antisense modulation of c/ebp alpha expression |
| 12/20/2001 | WO2001096574A1 Novel enzyme gene and its expression product |
| 12/20/2001 | WO2001096567A1 Novel g protein-coupled receptor protein and dna thereof |
| 12/20/2001 | WO2001096566A1 Gasc1 gene |
| 12/20/2001 | WO2001096559A2 Regulatable, catalytically active nucleic acids |
| 12/20/2001 | WO2001096532A2 Method of generating pluripotent mammalian cells by fusion of a cytoplast fragment with a karyoplast |
| 12/20/2001 | WO2001096525A2 A novel polypeptide, a pogo conversion unit 18 and the polynucleotide encoding the polypeptide |
| 12/20/2001 | WO2001096523A2 Polynucleotides related to colon cancer |
| 12/20/2001 | WO2001096397A2 Cd154 variants and uses thereof |
| 12/20/2001 | WO2001096393A2 Nucleotide and amino acid sequences of oocyte factors for altering ovarian follicular growth in vivo or in vitro |
| 12/20/2001 | WO2001096388A2 Compositions and methods for the therapy and diagnosis of colon cancer |
| 12/20/2001 | WO2001096385A1 Codon optimised recombinant dermaphagoides allergens |
| 12/20/2001 | WO2001096379A2 Immunization of dairy cattle with chimeric gapc protein against streptococcus infection |
| 12/20/2001 | WO2001096377A2 Vaccine for congenital tremors in pigs |
| 12/20/2001 | WO2001096376A2 Pro-apoptotic fragments of the dengue virus envelope glycoproteins |
| 12/20/2001 | WO2001096360A1 Antisense modulation of c/ebp beta expression |
| 12/20/2001 | WO2001095946A2 Combination product for carrying out a cytotoxic treatment in a mammal |
| 12/20/2001 | WO2001095919A2 A recombinant non-replicating virus expressing gm-csf and uses thereof to enhance immune responses |
| 12/20/2001 | WO2001088108A8 Neuronal serine-threonine protein kinase |
| 12/20/2001 | WO2001062933A3 Muteins of interleukin-13 (il-13) |
| 12/20/2001 | WO2001062207A3 Method for treating inflammatory bowel disease and other forms of gastrointestinal inflammation |
| 12/20/2001 | WO2001055367A8 Nucleic acids, proteins, and antibodies |
| 12/20/2001 | WO2001055303A3 Nucleic acids, proteins, and antibodies |
| 12/20/2001 | WO2001054719A3 Vaccine for the prophylactic or therapeutic immunization against hiv |
| 12/20/2001 | WO2001054474A8 Nucleic acids, proteins, and antibodies |
| 12/20/2001 | WO2001052888A3 Improved dna vaccines for production-type animals |
| 12/20/2001 | WO2001052874A3 Intra-tumoral administration of il-12 encoding nucleic acid molecules |
| 12/20/2001 | WO2001051640A3 Regulation of human mitochondrial transformylase |
| 12/20/2001 | WO2001051006A3 Cardiac-cell specific enhancer elements and uses thereof |
| 12/20/2001 | WO2001048208A3 Streptococcus pyogenes virulence genes and proteins and their use |
| 12/20/2001 | WO2001044295A3 Agonists and antagonists of the receptor gpr19 and their use in appetite control |
| 12/20/2001 | WO2001031016A3 Processed human chemokines phc-1 and phc-2 |
| 12/20/2001 | WO2000067775A9 Fibroblast growth factor 15 |
| 12/20/2001 | WO2000060076A3 Compositions for the treatment and diagnosis of breast cancer and methods for their use |
| 12/20/2001 | WO2000058358A9 49 human secreted proteins |
| 12/20/2001 | WO2000024765A8 Chlamydia antigens and corresponding dna fragments and uses thereof |
| 12/20/2001 | WO2000008133A9 NOVEL G PROTEIN-COUPLED RECEPTOR cDNA SEQUENCE |
| 12/20/2001 | US20010053844 Isolated human kinase proteins, nucleic acid molecules encoding human kinase proteins, and uses thereof |
| 12/20/2001 | US20010053770 Immunoreceptor tyrosine-based activation motif (ITAM); immunoreceptor tyrosine-based inhibition motif (ITIM); bispecific molecule such as fusion protein and vectors encoding it; treating allergic diseases |
| 12/20/2001 | US20010053769 Use of pro-apoptotic factors in treatment of atherosclerosis |
| 12/20/2001 | US20010053768 Gene therapy using replication competent targeted adenoviral vectors |
| 12/20/2001 | US20010053536 cDNA clone HDPBI30 that encodes a novel human 7-transmembrane receptor |
| 12/20/2001 | US20010053352 Adenovirus vectors containing cell status-specific response elements and methods of use thereof |
| 12/20/2001 | DE10037272A1 Identifying agents for treating cardiovascular disease, comprises determining the ability of potential agents to modify interaction between beta3 endonexin and beta3 integrin |
| 12/20/2001 | DE10027383A1 Nukleinsäure-Molekül umfassend eine für ein Chemokin, einen Neuropeptid-Präkursor oder mindestens ein Neuropeptid kodierende Nukleinsäuresequenz Nucleic acid molecule comprising a sequence coding for a chemokine, a neuropeptide precursor or at least one neuropeptide nucleic acid sequence |
| 12/20/2001 | DE10024171A1 Neuronale Serin-Threonin-Protein-Kinase Neuronal serine threonine protein kinase |
| 12/20/2001 | CA2412842A1 Combination product for carrying out a cytotoxic treatment in a mammal |
| 12/20/2001 | CA2412664A1 Regulatable, catalytically active nucleic acids |
| 12/20/2001 | CA2412257A1 Pro-apoptotic fragments of the dengue virus envelope glycoproteins |
| 12/20/2001 | CA2412223A1 Compositions and methods for the therapy and diagnosis of colon cancer |
| 12/20/2001 | CA2411472A1 Cd154 variants |
| 12/20/2001 | CA2411231A1 Codon optimised recombinant dermaphagoides allergens |
| 12/20/2001 | CA2410532A1 Nucleotide and amino acid sequences of oocyte factors for altering ovarian follicular growth in vivo or in vitro |
| 12/20/2001 | CA2410229A1 Vaccine for congenital tremors in pigs |
| 12/20/2001 | CA2351275A1 Use of polypeptides or nucleic acids for the diagnosis or treatment of skin disorders and wound healing and for the identification of pharmacologically active substances |
| 12/19/2001 | EP1164196A1 Retroviral vectors |
| 12/19/2001 | EP1164195A2 Adeno-associated virus with inverted terminal repeat sequences as promoter |
| 12/19/2001 | EP1163912A1 Gene therapeutics |
| 12/19/2001 | EP1163524A2 Methods of screening for colorectal cancer modulators |
| 12/19/2001 | EP1163522A1 Method for detecting superantigen activity in a biological sample |
| 12/19/2001 | EP1163515A1 Therapeutic and diagnostic tools for impaired glucose tolerance conditions |
| 12/19/2001 | EP1163373A1 Antisense modulation of cellular inhibitor of apoptosis-1 expression |
| 12/19/2001 | EP1163365A1 Diagnosis and therapy of premature ovarian failure |
| 12/19/2001 | EP1163356A1 Retroviral vectors comprising functional and non-functional splice donor and splice acceptor sites |
| 12/19/2001 | EP1163355A1 Anti-neoplastic viral agents comprising toxin gene under control of tumour cell-derived transcription factors |
| 12/19/2001 | EP1163349A2 Medical preparations for the treatment of alpha-galactosidase a deficiency |
| 12/19/2001 | EP1163342A1 Chlamydia antigens and corresponding dna fragments and uses thereof |
| 12/19/2001 | EP1163335A1 MATERIALS AND METHODS RELATING TO MODULATION OF p66 EXPRESSION |